<DOC>
	<DOC>NCT00765128</DOC>
	<brief_summary>The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having percutaneous nephrolithotomy for kidney stone disease.</brief_summary>
	<brief_title>Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Patients undergoing percutaneous nephrolithotomy for kidney stone disease History of nonsteroidal antiinflammatory drug allergy Asthma History of longterm opioid use Intraoperative blood loss greater than 300 mL Postoperative hemodynamic instability Active peptic ulcer disease Advanced renal impairment (Creatinine &gt; 2.0 mg/dL) Bleeding diathesis Current use of probenecid Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Percutaneous</keyword>
	<keyword>Nephrolithotomy</keyword>
	<keyword>Kidney stones</keyword>
</DOC>